The cornea is an important part of the human eye and its transparency is essential for normal vision. With the advancement of medical technology, many new surgical methods have been developed to treat corneal diseases, among which Pre Descemet's Endothelial Keratoplasty (PDEK) surgery is an attractive option. Since its first implementation in 2013, PDEK is gradually changing the landscape of corneal transplantation with its excellent surgical techniques and optimized therapeutic effects.
PDEK surgery is a special corneal endothelial transplantation technique, mainly used to treat corneal opacity caused by endothelial insufficiency. In this surgery, doctors transplant tissue including Descemet's membrane, endothelial cells and the sixth layer discovered by Harminder Dua - Pre Descemet's layer. The key to this innovative technology is its ability to provide the transparency needed to restore patients' sight.
For normal vision in the human eye, the cornea must remain transparent, which depends on the normal function of the endothelial cells.
The concept of PDEK surgery was first proposed by Professor Amar Agarwal in India in 2013, and the first surgery was subsequently performed under the guidance of Professor Harminder Dua. This technology has quickly attracted widespread attention because it breaks through the traditional whole cornea transplant method and can achieve better treatment results with less surgical trauma. Initially, PDEK surgery was performed to solve the problem of blister keratopathy caused by pseudophakia, in which the transparency of the cornea is greatly reduced, affecting vision.
PDEK surgery is mainly suitable for the following situations:
The PDEK procedure involves precise manipulation of the donor cornea, including removal of the required Pre Descemet's layer, and subsequent implantation into the patient's eye. The thickness and integrity of the donor cornea are crucial to the success of the operation, so the doctor must be very careful during the harvesting process.
PDEK surgery has less risk of rejection and faster vision recovery than traditional full corneal transplantation.
After surgery, patients will need to follow their doctor's instructions for regular antibiotics and steroids to prevent infection and promote healing. During the postoperative follow-up, the doctor will use various examinations to evaluate the effectiveness of the surgery and the patient's recovery. Recent studies have shown that patients who undergo PDEK surgery experience significant improvements in visual acuity and corneal clarity.
The development of PDEK surgery is still ongoing, and scientists and medical professionals hope to further study the regenerative capacity of endothelial cells to improve patients' postoperative outcomes and quality of life. With the continuous improvement of surgical techniques, it is more likely that a more perfect vision restoration solution will be created in the future.
PDEK surgery is undoubtedly a new hope for those who have lost their vision due to corneal problems, but can this technology be popularized to a wider range of patients?